Medicaid
Covered (preferred drug)What you need to qualify
- Age 18 and older
- Diagnosed obstructive sleep apnea (AHI of 15 or higher)
Qualification pathways
You can qualify through any one of these.
OSA in obese adults
All of:
- Diagnosis of moderate to severe obstructive sleep apnea
- Patient is an obese adult
- AHI > 15 as evidenced by sleep study within the prior 12 months
Documentation to bring
- Documentation of diagnosis of moderate to severe obstructive sleep apnea
- Sleep study performed within the prior 12 months showing AHI > 15
- Documentation that patient is an obese adult
- At 6-month renewal: documentation of at least 5% weight loss
- At 12-month renewal: documentation of improvement in obstructive sleep apnea
Approval and renewal
- Initial approval: 6 months
- Renewal: every 6 months
- To renew, the plan looks for at least 5% weight loss from the starting weight and At 6-month renewal: at least 5% weight loss required. At 12-month renewal: demonstrated improvement in obstructive sleep apnea required. Make sure your starting weight and date are in the chart now — renewal is measured against it.
Policy note: Zepbound is listed as a preferred GLP-1 agonist under the Obstructive Sleep Apnea therapeutic class on the Wyoming Medicaid PDL effective April 15, 2026. The policy requires a two-stage continuation review: re-authorization at 6 months requires at least 5% weight loss; re-authorization at 12 months requires demonstrated improvement in OSA. The policy states 'obese adults,' which implies an obesity requirement, but no explicit BMI threshold is stated. AHI > 15 is required (consistent with moderate-to-severe OSA). No PAP/CPAP trial is required per this document. The document does not address Zepbound for weight_loss indication, so no entry is emitted for that indication.
Policy effective April 15, 2026 · verified June 4, 2026 · source: pdl-2026-041526.pdf